• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素耐药性:现状和遏制情景。

Artemisinin resistance: current status and scenarios for containment.

机构信息

Mahidol Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok10400, Thailand.

出版信息

Nat Rev Microbiol. 2010 Apr;8(4):272-80. doi: 10.1038/nrmicro2331. Epub 2010 Mar 8.

DOI:10.1038/nrmicro2331
PMID:20208550
Abstract

Artemisinin combination therapies are the first-line treatments for uncomplicated Plasmodium falciparum malaria in most malaria-endemic countries. Recently, partial artemisinin-resistant P. falciparum malaria has emerged on the Cambodia-Thailand border. Exposure of the parasite population to artemisinin monotherapies in subtherapeutic doses for over 30 years, and the availability of substandard artemisinins, have probably been the main driving force in the selection of the resistant phenotype in the region. A multifaceted containment programme has recently been launched, including early diagnosis and appropriate treatment, decreasing drug pressure, optimising vector control, targeting the mobile population, strengthening management and surveillance systems, and operational research. Mathematical modelling can be a useful tool to evaluate possible strategies for containment.

摘要

青蒿素联合疗法是大多数疟疾流行国家治疗无并发症恶性疟原虫疟疾的一线药物。最近,柬埔寨-泰国边境地区出现了部分青蒿素耐药恶性疟原虫。三十多年来,寄生虫种群暴露在亚治疗剂量的青蒿素单一疗法中,以及不合格青蒿素的供应,可能是该地区耐药表型选择的主要驱动力。最近启动了一项多方面的遏制计划,包括早期诊断和适当治疗、降低药物压力、优化病媒控制、针对流动人口、加强管理和监测系统以及开展业务研究。数学建模可以成为评估遏制策略的有用工具。

相似文献

1
Artemisinin resistance: current status and scenarios for containment.青蒿素耐药性:现状和遏制情景。
Nat Rev Microbiol. 2010 Apr;8(4):272-80. doi: 10.1038/nrmicro2331. Epub 2010 Mar 8.
2
Emerging artemisinin resistance in the border areas of Thailand.泰国边境地区出现青蒿素抗药性。
Expert Rev Clin Pharmacol. 2013 May;6(3):307-22. doi: 10.1586/ecp.13.17.
3
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.泰国西部边境地区青蒿素耐药疟疾的出现:一项纵向研究。
Lancet. 2012 May 26;379(9830):1960-6. doi: 10.1016/S0140-6736(12)60484-X. Epub 2012 Apr 5.
4
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.柬埔寨三突变(包括kelch13 C580Y)导致双氢青蒿素-哌喹耐药:一项观察性队列研究。
Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.
5
Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand.疟原虫 falciparum K13 突变体对泰国青蒿素联合疗法的自然选择。
Clin Microbiol Infect. 2016 Mar;22(3):285.e1-8. doi: 10.1016/j.cmi.2015.10.027. Epub 2015 Nov 5.
6
Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.界定青蒿素耐药恶性疟原虫的体内表型:一种建模方法。
PLoS Med. 2015 Apr 28;12(4):e1001823. doi: 10.1371/journal.pmed.1001823. eCollection 2015 Apr.
7
How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.如何遏制青蒿素和多药耐药恶性疟原虫疟疾。
Trends Parasitol. 2017 May;33(5):353-363. doi: 10.1016/j.pt.2017.01.004. Epub 2017 Feb 7.
8
Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.在抗疟药耐药性遏制项目之后,对泰国疟原虫分离株的表型和基因型特征进行分析。
Malar J. 2018 May 15;17(1):197. doi: 10.1186/s12936-018-2347-9.
9
Geographic expansion of artemisinin resistance.青蒿素耐药性的地理扩张。
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/taz030.
10
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia.最后剩下的人是最具抗药性的:在柬埔寨消除抗青蒿素疟疾。
Malar J. 2009 Feb 20;8:31. doi: 10.1186/1475-2875-8-31.

引用本文的文献

1
Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study.使用针对幼年血吸虫的驱虫药物进行群体药物管理对血吸虫病的人群水平影响:一项建模研究
Lancet Microbe. 2025 Jul;6(7):101065. doi: 10.1016/j.lanmic.2024.101065. Epub 2025 May 21.
2
Integral Solvent-Induced Protein Precipitation for Target-Engagement Studies in .用于……中靶点结合研究的整体溶剂诱导蛋白质沉淀法
ACS Infect Dis. 2024 Dec 13;10(12):4073-4086. doi: 10.1021/acsinfecdis.4c00418. Epub 2024 Dec 4.
3
Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana.

本文引用的文献

1
High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.高疟原虫清除率的遗传力表明柬埔寨西部青蒿素耐药性存在遗传基础。
J Infect Dis. 2010 May 1;201(9):1326-30. doi: 10.1086/651562.
2
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.寄生虫过度感染和低剂量用药是抗疟药物产生抗药性的一个重要原因。
Malar J. 2009 Nov 11;8:253. doi: 10.1186/1475-2875-8-253.
3
Artemisinin-resistant malaria in Asia.亚洲的抗青蒿素疟疾
圭亚那疟原虫无性系谱系的时空动态。
PLoS Pathog. 2024 Jun 13;20(6):e1012013. doi: 10.1371/journal.ppat.1012013. eCollection 2024 Jun.
4
Effect of the Affordable Medicines Facility for malaria (AMFm) on the availability of antimalarials in Nigeria.疟疾可负担药品设施(AMFm)对尼日利亚抗疟药可及性的影响。
Malariaworld J. 2015 May 9;6:5. doi: 10.5281/zenodo.10870095. eCollection 2015.
5
Combating antimicrobial resistance in malaria, HIV and tuberculosis.抗疟疾、艾滋病毒和结核病中的抗菌药物耐药性
Nat Rev Drug Discov. 2024 Jun;23(6):461-479. doi: 10.1038/s41573-024-00933-4. Epub 2024 May 15.
6
Access to quality-assured artemisinin-based combination therapy and associated factors among clients of selected private drug outlets in Uganda.乌干达部分私立药店客户获得有质量保证的青蒿素复方疗法及相关因素
Malar J. 2024 Apr 30;23(1):128. doi: 10.1186/s12936-024-04956-5.
7
Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.乌干达部分地区的共付机制:私营药店中质量有保证的青蒿素复方疗法的供应情况、市场份额和价格。
PLoS One. 2024 Mar 27;19(3):e0295198. doi: 10.1371/journal.pone.0295198. eCollection 2024.
8
Temporal and spatial dynamics of clonal lineages in Guyana.圭亚那克隆谱系的时空动态
bioRxiv. 2024 Feb 1:2024.01.31.578156. doi: 10.1101/2024.01.31.578156.
9
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.1,3-二苯脲基羟肟酸作为一种有前途的支架,用于生成有效的抗疟原虫组蛋白去乙酰化酶抑制剂。
Sci Rep. 2023 Nov 29;13(1):21006. doi: 10.1038/s41598-023-47959-z.
10
Health Emergency Risk Management in World Health Organization - South-East Asia Region during 2014-2023: synthesis of experiences.2014 - 2023年世界卫生组织东南亚区域的卫生应急风险管理:经验总结
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100304. doi: 10.1016/j.lansea.2023.100304. eCollection 2023 Nov.
N Engl J Med. 2009 Jul 30;361(5):540-1. doi: 10.1056/NEJMc0900231.
4
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
5
Countries race to contain resistance to key antimalarial.各国竞相控制对关键抗疟药物的耐药性。
Lancet. 2009 Jul 25;374(9686):277-80. doi: 10.1016/s0140-6736(09)61349-0.
6
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.奎宁与蒿甲醚-本芴醇治疗乌干达儿童单纯性恶性疟的疗效比较:随机试验
BMJ. 2009 Jul 21;339:b2763. doi: 10.1136/bmj.b2763.
7
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations.优化磷酸氯喹治疗时机以降低低流行区泰缅边境人群中疟原虫传播。
Malar J. 2009 Jul 15;8:159. doi: 10.1186/1475-2875-8-159.
8
Seventy-five years of Resochin in the fight against malaria.氯喹在抗击疟疾斗争中的75年历程。
Parasitol Res. 2009 Sep;105(3):609-27. doi: 10.1007/s00436-009-1524-8. Epub 2009 Jul 11.
9
The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?).数学建模在疟疾消除和根除中的作用(评论:疟疾能否被消除?)
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):643-4. doi: 10.1016/j.trstmh.2009.01.027. Epub 2009 Mar 10.
10
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.坦桑尼亚北部恶性疟原虫对周效磺胺/乙胺嘧啶的高抗性以及第581位密码子二氢蝶酸合酶(DHPS)抗性突变的出现。
PLoS One. 2009;4(2):e4569. doi: 10.1371/journal.pone.0004569. Epub 2009 Feb 24.